Biography

About

Gaia has over seven years of life sciences consulting experience, leading and supporting a range of market access and health policy projects, helping clients improving access to medicines and achieving commercial success. ​

Gaia has worked on projects at global level and national level and her experience spans market access and reimbursement, launch excellence, health systems analysis and stakeholder engagement. ​

Gaia has extensive health policy experience, including advocacy and policy strategy development for health system change and has authored various policy papers, reports, and peer-reviewed publications. She was the author of the 2024 IFPMA “Always Innovating” report, a testament to the global pharmaceutical industry efforts to innovate, improve global health outcomes and contribute to the global economy and employment.​

She has partnered with several global pharmaceutical companies as well as national and international pharmaceutical trade associations. ​

She holds an MS in Global Politics from the London School of Economics and Political Science and a and a BSc in Political Science and International Relations.

Back to leadership team
Authored Posts

Published works and authored insights

Man presenting plans on paper to two other business people
May 27, 2026
Why NICE’s new cost-effectiveness threshold matters for pharmaceutical access in the UK
NICE updates its cost-effectiveness threshold. Discover the implications of this change for the UK HTA, patient access, and pricing strategy.
Businessman standing at conference table full of people in office presenting
May 27, 2026
What Is the EU’s pharmaceutical legislation agreement telling the industry?
Overview of the EU pharmaceutical legislation agreement and its implications for the industry, from market exclusivity to regulatory reform.